AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.520
+0.070 (2.03%)
Mar 9, 2026, 4:00 PM EDT - Market closed
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of March 9, 2026. Its market cap has increased by 15.06% in one year.
Market Cap
1.07B
Enterprise Value
661.36M
1-Year Change
15.06%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.07B, a decrease of -93.19%. That is a compound annual growth rate of -40.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.15B |
| Pharming Group | 1.06B |
| ArriVent BioPharma | 1.04B |
| Inhibrx Biosciences | 1.01B |
| Xeris Biopharma Holdings | 1.00B |
| UroGen Pharma | 996.04M |
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |